Zheng et al. found that fibrinogen-albumin ratio and platelet-lymphocyte ratio score was a prognostic factor of breast cancer [33], and NLR has been shown to predict the efficacy of neoadjuvant chemotherapy in breast cancer [34,35]. This evidence concerns the gene ALB and breast carcinoma.